0001375151-19-000002.txt : 20190111
0001375151-19-000002.hdr.sgml : 20190111
20190111160702
ACCESSION NUMBER: 0001375151-19-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190110
FILED AS OF DATE: 20190111
DATE AS OF CHANGE: 20190111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FARR STEPHEN J
CENTRAL INDEX KEY: 0001247666
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 19522425
MAIL ADDRESS:
STREET 1: SFARR@ZOGENIX.COM
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_154724080525499.xml
FORM 4
X0306
4
2019-01-10
0
0001375151
ZOGENIX, INC.
ZGNX
0001247666
FARR STEPHEN J
C/O ZOGENIX, INC.
5858 HORTON STREET, SUITE 455
EMERYVILLE
CA
94608
1
1
0
0
President and CEO
Common Stock
2019-01-10
4
M
0
312
20
A
52259
D
Common Stock
2019-01-10
4
S
0
312
45
D
51947
D
Common Stock
2019-01-10
4
M
0
35001
10.35
A
86948
D
Common Stock
2019-01-10
4
S
0
35001
45
D
51947
D
Common Stock
2019-01-10
4
M
0
55000
10.20
A
106947
D
Common Stock
2019-01-10
4
S
0
55000
45
D
51947
D
Stock Option (Right to Buy)
20.0
2019-01-10
4
M
0
312
0
D
2019-08-31
Common Stock
312.0
5000
D
Stock Option (Right to Buy)
10.35
2019-01-10
4
M
0
35001
0
D
2026-03-13
Common Stock
35001.0
164999
D
Stock Option (Right to Buy)
10.2
2019-01-10
4
M
0
55000
0
D
2027-03-13
Common Stock
55000.0
110000
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The option award was granted on September 1, 2009 and vests in a series of twenty-four (24) successive, equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service to the Company on each applicable vesting date.
The option award was granted on March 14, 2016 and vests in a series of forty-eight (48) successive, equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service to the Company on each applicable vesting date.
The option award was granted on March 14, 2017 and vests in a series of forty-eight (48) successive, equal monthly installments beginning with the one-month anniversary of the grant date, subject to the Reporting Person's continued service to the Company on each applicable vesting date.
/s/ Thomas Doyle, Attorney-in-fact for Stephen Farr
2019-01-11